Theravance Biopharma Competitors and Similar CompaniesClear all

Theravance Biopharma's competitors and similar companies include Acceleron Pharma, Inflazome, Prothena and Genentech.
Theravance Biopharma
Theravance Biopharma
Theravance Biopharma is a biopharmaceutical company which provides medicines to treat serious illnesses.
Acceleron Pharma
Acceleron Pharma
Acceleron Pharma is a clinical-stage biopharmaceutical company.
Inflazome
Inflazome
Inflazome engages in developing orally available drugs to address clinical unmet needs in inflammatory diseases by targeting the inflammasome.
Prothena
Prothena
Prothena is a global biotechnology company seeking to fundamentally alter the course of progressive diseases.
Genentech
Genentech
Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.
Founding Date
Founding Date
1996
Founding Date
2003
Founding Date
2016
Founding Date
2012
Founding Date
1976
Type
Type
Public
Type
Subsidiary
Type
Subsidiary
Type
Public
Type
Subsidiary
Tags
Locations
Locations
Dublin, IE HQ
San Francisco, US
Locations
Cambridge, US HQ
Zug, CH
Locations
Dublin 2, IE HQ
Brisbane City, AU
Cambridge, GB
Locations
Dublin, IE HQ
South San Francisco, US
Locations
South San Francisco, US HQ
Hillsboro, US
Oceanside, US
Portland, US
South San Francisco, US
South San Francisco, US
South San Francisco, US
see more
Employees
Employees
97
Employees
636% decrease
Employees
156% decrease
Employees
163
Employees
18,077
Valuation ($)
Valuation ($)
429 m
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
983.1 m
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
$107.5m (FY, 2025)
Revenue (est.)
$92.5m (FY, 2020)
Revenue (est.)
N/A
Revenue (est.)
$9.7m (FY, 2025)
Revenue (est.)
N/A
Net income
Net income
$105.9m (FY, 2025)
Net income
($166m) (FY, 2020)
Net income
N/A
Net income
($244.1m) (FY, 2025)
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 55m
Total funding raised
$ 141.8m
Total funding raised
$ 17m
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Acceleron Pharma
HQ
Cambridge, US

Acceleron Pharma is a clinical-stage biopharmaceutical company.

View company
Inflazome
HQ
Dublin 2, IE

Inflazome engages in developing orally available drugs to address clinical unmet needs in inflammatory diseases by targeting the inflammasome.

View company
Prothena
HQ
Dublin, IE
Employees
163

Prothena is a global biotechnology company seeking to fundamentally alter the course of progressive diseases.

View company
Genentech
HQ
South San Francisco, US

Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.

View company